CIBC Bancorp USA’s Transmedics TMDX Stock Holding History

CIBC Bancorp USA’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$398K	Buy	+3,544	New	+$415K	﹤0.01%	962

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC Bancorp USA's TMDX Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Transmedics (TMDX) in Q3 2025: 3,544 shares worth $398K. The stake represents ﹤0.01% of the portfolio and ranks #962 among its holdings.

388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

CIBC Bancorp USA held 3,544 shares of Transmedics worth $398K as of Q3 2025.
Transmedics was a new CIBC Bancorp USA position in Q3 2025.
Transmedics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #962 holding.
388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.